Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-038774

EVP & Chief Commercial Officer sold 295 shares at $54.78 ($16,160)

From the SEC's structured data for this filing

Trades in this filing

Harris Erik · EVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-06-19 Sale : show line 1 in the form −295 $54.78 $16,160 36,160 D
Open-market sales · 295 sh · avg $54.78 · $16,160
Loading xslF345X03/doc4.xml…